Appco Pharma LLC Recalls

3 recalls on record in the United States

drugs: 3
drugs Class II
2026-04-08

Appco Pharma LLC recalls Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle,

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

View recall details →
drugs Class II
2026-04-08

Appco Pharma LLC recalls Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle,

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

View recall details →
drugs Class II
2026-04-08

Appco Pharma LLC recalls Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle,

cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

View recall details →